TimLautenschlaegerMD

Radiation Oncology • Indianapolis, IN

Assistant Professor, Radiation Oncology, Indiana University

Join to view full profile

Dr. Lautenschlaeger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lautenschlaeger's full profile

Already have an account?

Office
535 Barnhill Dr
# ROUTE041
Indianapolis, IN 46202
Phone+1 317-944-2524

Fax+1 317-944-2486

Education & Training

Ohio State University HospitalResidency, Radiation Oncology, 2011 - 2015
Ohio State University HospitalInternship, Transitional Year, 2010 - 2011
Philipps University of Marburg Faculty of MedicineClass of 2006

Certifications & Licensure

IN State Medical License 2015 - 2025
OH State Medical License 2010 - 2015
American Board of Radiology Radiation Oncology

Clinical Trials

Biomarker Identification for Bladder Cancer Patients Start of enrollment: 2014 Jan 21
Active, not recruiting
Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy Start of enrollment: 2012 Oct 04
Active, not recruiting
Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung Start of enrollment: 2017 Oct 20
Terminated
Phase 1
SABR for T1-2a N1 NSCLC Start of enrollment: 2022 Jan 01
Withdrawn
Phase 2
Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest Wall Start of enrollment: 2020 Oct 02
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Canc...
John J Coen, Joseph P Rodgers, Philip J Saylor, Cheryl T Lee, Chin-Lee Wu
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiat...
Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser H Hanna, Sandra Althouse
International Journal of Radiation Oncology, Biology, Physics. 2024-10-26
1 citations
Preoperative stereotactic radiosurgery for patients with 1-4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694).
Namita Agrawal, Jack M Shireman, Kevin Shiue, Aaron Kamer, LaKeisha Boyd
Neuro-Oncology Practice. 2024-10-01

Journal Articles

TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas - a Pilot Prospective Study
Tim Lautenschlaeger, MD, Clinical Cancer Research

Press Mentions

MicroRNA-31 Might Predict Lung-Cancer SpreadSeptember 24th, 2013